Immunohistochemical analysis of pro-apoptotic Bid level in chronic hepatitis, hepatocellular carcinoma and liver metastases.

[1]  S. Zhuang,et al.  p38 Mitogen-activated Protein Kinase Mediates Bid Cleavage, Mitochondrial Dysfunction, and Caspase-3 Activation during Apoptosis Induced by Singlet Oxygen but Not by Hydrogen Peroxide* , 2000, The Journal of Biological Chemistry.

[2]  V. Desmet,et al.  Fas and Fas ligand: strong co‐expression in human hepatocytes surrounding hepatocellular carcinoma; can cancer induce suicide in peritumoural cells? , 2000, The Journal of pathology.

[3]  H. Saito,et al.  Bcl-2 related proteins are dramatically induced at the early stage of differentiation in human liver cancer cells by a histone deacetylase inhibitor projecting an anti-apoptotic role during this period. , 2000, Oncology reports.

[4]  M. Fiorentino,et al.  High levels of BCL-2 messenger RNA detected by in situ hybridization in human hepatocellular and cholangiocellular carcinomas. , 1999, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[5]  S. Korsmeyer,et al.  Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis , 1999, Nature.

[6]  T. Miyashita,et al.  Overexpression of Bcl-2 protects human hepatoma cells from Fas-antibody-mediated apoptosis. , 1999, Journal of hepatology.

[7]  Junying Yuan,et al.  Solution Structure of BID, an Intracellular Amplifier of Apoptotic Signaling , 1999, Cell.

[8]  E. Zarling,et al.  Immunohistochemical evaluation of bcl-2 gene family expression in liver of hepatitis C and cirrhotic patients: a novel mechanism to explain the high incidence of hepatocarcinoma in cirrhotics , 1999, American Journal of Gastroenterology.

[9]  Junying Yuan,et al.  Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis , 1998, Cell.

[10]  Xiaodong Wang,et al.  Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors , 1998, Cell.

[11]  B. Harvey,et al.  Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ , 1997, Journal of virology.

[12]  R. Crystal,et al.  Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. , 1997, Human gene therapy.

[13]  C. Milliman,et al.  BID: a novel BH3 domain-only death agonist. , 1996, Genes & development.

[14]  E. Wisse,et al.  Cell biology and kinetics of Kupffer cells in the liver. , 1989, International review of cytology.

[15]  A. Benedetti,et al.  A quantitative evaluation of apoptotic bodies in rat liver. , 2008, Liver.

[16]  M. Kojiro,et al.  Pathology of Hepatocellular Carcinoma , 2006 .

[17]  B. Fleshler,et al.  The Liver: Biology and Pathobiology , 1983 .

[18]  O. James,et al.  Kupffer cell phagocytosis in relation to BSP clearance in liver and inflammatory bowel diseases , 1980, Digestive diseases and sciences.